Frontiers in Surgery-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1240475, encodeId=677e12404e5c0, content=Independent Review 等第2个审稿人意见已经2个多月了。。凉凉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2665416535, createdName=一路同行, createdTime=Tue Aug 23 10:39:29 CST 2022, time=2022-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095213, encodeId=ad3b209521358, content=这个杂志版面费3500美元？那么贵啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99308103880, createdName=ms9000001756415644, createdTime=Fri Oct 21 16:33:42 CST 2022, time=2022-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239942, encodeId=84121239942ce, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：骨科 经验分享：小修一次，接收挺快 15 Aug 2022 Article accepted for publication. 20 Jul 2022 Review of Review Editor 2 finalized. Submitting Author re-submitted manuscript. You posted new comments. 14 Jul 2022 Interactive review forum activated automatically. 11 Jul 2022 Review of Reviewer 1 is finalized. 19 Jun 2022 Submitting Author submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be412313672, createdName=军爷123321, createdTime=Sat Aug 20 09:01:55 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089762, encodeId=11b72089e62ab, content=偏重的研究方向：外科 经验分享：各位大佬，快2个月了只有1个审稿人给了意见，请问用什么途径催稿呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85af6425685, createdName=ms8000000359760847, createdTime=Thu Sep 22 13:45:29 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225936, encodeId=86c31225936fe, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：4个审稿人都审稿结束了，进入review finalized 这个状态10天了，有知道这是什么情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=219a6417862, createdName=ms1000000108142926, createdTime=Sun Jun 12 10:16:37 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230074, encodeId=37db12300e4eb, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：真垃圾，三个审稿人都同意发表了，主编最后给拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bc0e6387745, createdName=ms6000001401670212, createdTime=Sat Jul 02 08:09:47 CST 2022, time=2022-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243293, encodeId=768a124329312, content=请问现在frontiers系列被预警概率大不大啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ffe2800746, createdName=504528319, createdTime=Mon Sep 05 13:11:52 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226035, encodeId=f9721226035b8, content=？？？？？？？？？？？？？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53128143603, createdName=ms8000001039313949, createdTime=Sun Jun 12 21:02:14 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238991, encodeId=14b4123899110, content=请问下这个是sci吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56145605225, createdName=ms2000001619512986, createdTime=Tue Aug 16 11:17:01 CST 2022, time=2022-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239374, encodeId=44d212393e493, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：22年2月份投过一次，1个月2个审稿意见返回，返修后1周接受。现在Frontiers稿件超级多，找不到编辑和审稿人都很常见，审稿时间随之延长。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97a06490553, createdName=TMAC1992, createdTime=Wed Aug 17 20:55:55 CST 2022, time=2022-08-17, status=1, ipAttribution=)]

2022-08-23 一路同行

Independent Review 等第2个审稿人意见已经2个多月了。。凉凉

56 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1240475, encodeId=677e12404e5c0, content=Independent Review 等第2个审稿人意见已经2个多月了。。凉凉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2665416535, createdName=一路同行, createdTime=Tue Aug 23 10:39:29 CST 2022, time=2022-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095213, encodeId=ad3b209521358, content=这个杂志版面费3500美元？那么贵啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99308103880, createdName=ms9000001756415644, createdTime=Fri Oct 21 16:33:42 CST 2022, time=2022-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239942, encodeId=84121239942ce, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：骨科 经验分享：小修一次，接收挺快 15 Aug 2022 Article accepted for publication. 20 Jul 2022 Review of Review Editor 2 finalized. Submitting Author re-submitted manuscript. You posted new comments. 14 Jul 2022 Interactive review forum activated automatically. 11 Jul 2022 Review of Reviewer 1 is finalized. 19 Jun 2022 Submitting Author submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be412313672, createdName=军爷123321, createdTime=Sat Aug 20 09:01:55 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089762, encodeId=11b72089e62ab, content=偏重的研究方向：外科 经验分享：各位大佬，快2个月了只有1个审稿人给了意见，请问用什么途径催稿呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85af6425685, createdName=ms8000000359760847, createdTime=Thu Sep 22 13:45:29 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225936, encodeId=86c31225936fe, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：4个审稿人都审稿结束了，进入review finalized 这个状态10天了，有知道这是什么情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=219a6417862, createdName=ms1000000108142926, createdTime=Sun Jun 12 10:16:37 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230074, encodeId=37db12300e4eb, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：真垃圾，三个审稿人都同意发表了，主编最后给拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bc0e6387745, createdName=ms6000001401670212, createdTime=Sat Jul 02 08:09:47 CST 2022, time=2022-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243293, encodeId=768a124329312, content=请问现在frontiers系列被预警概率大不大啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ffe2800746, createdName=504528319, createdTime=Mon Sep 05 13:11:52 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226035, encodeId=f9721226035b8, content=？？？？？？？？？？？？？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53128143603, createdName=ms8000001039313949, createdTime=Sun Jun 12 21:02:14 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238991, encodeId=14b4123899110, content=请问下这个是sci吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56145605225, createdName=ms2000001619512986, createdTime=Tue Aug 16 11:17:01 CST 2022, time=2022-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239374, encodeId=44d212393e493, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：22年2月份投过一次，1个月2个审稿意见返回，返修后1周接受。现在Frontiers稿件超级多，找不到编辑和审稿人都很常见，审稿时间随之延长。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97a06490553, createdName=TMAC1992, createdTime=Wed Aug 17 20:55:55 CST 2022, time=2022-08-17, status=1, ipAttribution=)]

2022-10-21 ms9000001756415644

这个杂志版面费3500美元？那么贵啊

50 0

[GetPortalCommentsPageByObjectIdResponse(id=1240475, encodeId=677e12404e5c0, content=Independent Review 等第2个审稿人意见已经2个多月了。。凉凉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2665416535, createdName=一路同行, createdTime=Tue Aug 23 10:39:29 CST 2022, time=2022-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095213, encodeId=ad3b209521358, content=这个杂志版面费3500美元？那么贵啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99308103880, createdName=ms9000001756415644, createdTime=Fri Oct 21 16:33:42 CST 2022, time=2022-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239942, encodeId=84121239942ce, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：骨科 经验分享：小修一次，接收挺快 15 Aug 2022 Article accepted for publication. 20 Jul 2022 Review of Review Editor 2 finalized. Submitting Author re-submitted manuscript. You posted new comments. 14 Jul 2022 Interactive review forum activated automatically. 11 Jul 2022 Review of Reviewer 1 is finalized. 19 Jun 2022 Submitting Author submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be412313672, createdName=军爷123321, createdTime=Sat Aug 20 09:01:55 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089762, encodeId=11b72089e62ab, content=偏重的研究方向：外科 经验分享：各位大佬，快2个月了只有1个审稿人给了意见，请问用什么途径催稿呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85af6425685, createdName=ms8000000359760847, createdTime=Thu Sep 22 13:45:29 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225936, encodeId=86c31225936fe, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：4个审稿人都审稿结束了，进入review finalized 这个状态10天了，有知道这是什么情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=219a6417862, createdName=ms1000000108142926, createdTime=Sun Jun 12 10:16:37 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230074, encodeId=37db12300e4eb, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：真垃圾，三个审稿人都同意发表了，主编最后给拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bc0e6387745, createdName=ms6000001401670212, createdTime=Sat Jul 02 08:09:47 CST 2022, time=2022-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243293, encodeId=768a124329312, content=请问现在frontiers系列被预警概率大不大啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ffe2800746, createdName=504528319, createdTime=Mon Sep 05 13:11:52 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226035, encodeId=f9721226035b8, content=？？？？？？？？？？？？？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53128143603, createdName=ms8000001039313949, createdTime=Sun Jun 12 21:02:14 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238991, encodeId=14b4123899110, content=请问下这个是sci吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56145605225, createdName=ms2000001619512986, createdTime=Tue Aug 16 11:17:01 CST 2022, time=2022-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239374, encodeId=44d212393e493, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：22年2月份投过一次，1个月2个审稿意见返回，返修后1周接受。现在Frontiers稿件超级多，找不到编辑和审稿人都很常见，审稿时间随之延长。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97a06490553, createdName=TMAC1992, createdTime=Wed Aug 17 20:55:55 CST 2022, time=2022-08-17, status=1, ipAttribution=)]

2022-08-20 军爷123321

审稿速度:2.0 | 投稿命中率:95.0
偏重的研究方向：骨科
经验分享：小修一次，接收挺快
15 Aug 2022
Article accepted for publication.
20 Jul 2022
Review of Review Editor 2 finalized.
Submitting Author re-submitted manuscript.
You posted new comments.
14 Jul 2022
Interactive review forum activated automatically.
11 Jul 2022
Review of Reviewer 1 is finalized.
19 Jun 2022
Submitting Author submitted manuscript.

62 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1240475, encodeId=677e12404e5c0, content=Independent Review 等第2个审稿人意见已经2个多月了。。凉凉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2665416535, createdName=一路同行, createdTime=Tue Aug 23 10:39:29 CST 2022, time=2022-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095213, encodeId=ad3b209521358, content=这个杂志版面费3500美元？那么贵啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99308103880, createdName=ms9000001756415644, createdTime=Fri Oct 21 16:33:42 CST 2022, time=2022-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239942, encodeId=84121239942ce, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：骨科 经验分享：小修一次，接收挺快 15 Aug 2022 Article accepted for publication. 20 Jul 2022 Review of Review Editor 2 finalized. Submitting Author re-submitted manuscript. You posted new comments. 14 Jul 2022 Interactive review forum activated automatically. 11 Jul 2022 Review of Reviewer 1 is finalized. 19 Jun 2022 Submitting Author submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be412313672, createdName=军爷123321, createdTime=Sat Aug 20 09:01:55 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089762, encodeId=11b72089e62ab, content=偏重的研究方向：外科 经验分享：各位大佬，快2个月了只有1个审稿人给了意见，请问用什么途径催稿呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85af6425685, createdName=ms8000000359760847, createdTime=Thu Sep 22 13:45:29 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225936, encodeId=86c31225936fe, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：4个审稿人都审稿结束了，进入review finalized 这个状态10天了，有知道这是什么情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=219a6417862, createdName=ms1000000108142926, createdTime=Sun Jun 12 10:16:37 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230074, encodeId=37db12300e4eb, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：真垃圾，三个审稿人都同意发表了，主编最后给拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bc0e6387745, createdName=ms6000001401670212, createdTime=Sat Jul 02 08:09:47 CST 2022, time=2022-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243293, encodeId=768a124329312, content=请问现在frontiers系列被预警概率大不大啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ffe2800746, createdName=504528319, createdTime=Mon Sep 05 13:11:52 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226035, encodeId=f9721226035b8, content=？？？？？？？？？？？？？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53128143603, createdName=ms8000001039313949, createdTime=Sun Jun 12 21:02:14 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238991, encodeId=14b4123899110, content=请问下这个是sci吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56145605225, createdName=ms2000001619512986, createdTime=Tue Aug 16 11:17:01 CST 2022, time=2022-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239374, encodeId=44d212393e493, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：22年2月份投过一次，1个月2个审稿意见返回，返修后1周接受。现在Frontiers稿件超级多，找不到编辑和审稿人都很常见，审稿时间随之延长。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97a06490553, createdName=TMAC1992, createdTime=Wed Aug 17 20:55:55 CST 2022, time=2022-08-17, status=1, ipAttribution=)]

2022-09-22 ms8000000359760847

偏重的研究方向：外科
经验分享：各位大佬，快2个月了只有1个审稿人给了意见，请问用什么途径催稿呢

50 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1240475, encodeId=677e12404e5c0, content=Independent Review 等第2个审稿人意见已经2个多月了。。凉凉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2665416535, createdName=一路同行, createdTime=Tue Aug 23 10:39:29 CST 2022, time=2022-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095213, encodeId=ad3b209521358, content=这个杂志版面费3500美元？那么贵啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99308103880, createdName=ms9000001756415644, createdTime=Fri Oct 21 16:33:42 CST 2022, time=2022-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239942, encodeId=84121239942ce, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：骨科 经验分享：小修一次，接收挺快 15 Aug 2022 Article accepted for publication. 20 Jul 2022 Review of Review Editor 2 finalized. Submitting Author re-submitted manuscript. You posted new comments. 14 Jul 2022 Interactive review forum activated automatically. 11 Jul 2022 Review of Reviewer 1 is finalized. 19 Jun 2022 Submitting Author submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be412313672, createdName=军爷123321, createdTime=Sat Aug 20 09:01:55 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089762, encodeId=11b72089e62ab, content=偏重的研究方向：外科 经验分享：各位大佬，快2个月了只有1个审稿人给了意见，请问用什么途径催稿呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85af6425685, createdName=ms8000000359760847, createdTime=Thu Sep 22 13:45:29 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225936, encodeId=86c31225936fe, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：4个审稿人都审稿结束了，进入review finalized 这个状态10天了，有知道这是什么情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=219a6417862, createdName=ms1000000108142926, createdTime=Sun Jun 12 10:16:37 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230074, encodeId=37db12300e4eb, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：真垃圾，三个审稿人都同意发表了，主编最后给拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bc0e6387745, createdName=ms6000001401670212, createdTime=Sat Jul 02 08:09:47 CST 2022, time=2022-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243293, encodeId=768a124329312, content=请问现在frontiers系列被预警概率大不大啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ffe2800746, createdName=504528319, createdTime=Mon Sep 05 13:11:52 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226035, encodeId=f9721226035b8, content=？？？？？？？？？？？？？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53128143603, createdName=ms8000001039313949, createdTime=Sun Jun 12 21:02:14 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238991, encodeId=14b4123899110, content=请问下这个是sci吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56145605225, createdName=ms2000001619512986, createdTime=Tue Aug 16 11:17:01 CST 2022, time=2022-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239374, encodeId=44d212393e493, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：22年2月份投过一次，1个月2个审稿意见返回，返修后1周接受。现在Frontiers稿件超级多，找不到编辑和审稿人都很常见，审稿时间随之延长。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97a06490553, createdName=TMAC1992, createdTime=Wed Aug 17 20:55:55 CST 2022, time=2022-08-17, status=1, ipAttribution=)]

2022-06-12 ms1000000108142926

审稿速度:6.0 | 投稿命中率:50.0
经验分享：4个审稿人都审稿结束了，进入review finalized 这个状态10天了，有知道这是什么情况啊？

79 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1240475, encodeId=677e12404e5c0, content=Independent Review 等第2个审稿人意见已经2个多月了。。凉凉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2665416535, createdName=一路同行, createdTime=Tue Aug 23 10:39:29 CST 2022, time=2022-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095213, encodeId=ad3b209521358, content=这个杂志版面费3500美元？那么贵啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99308103880, createdName=ms9000001756415644, createdTime=Fri Oct 21 16:33:42 CST 2022, time=2022-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239942, encodeId=84121239942ce, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：骨科 经验分享：小修一次，接收挺快 15 Aug 2022 Article accepted for publication. 20 Jul 2022 Review of Review Editor 2 finalized. Submitting Author re-submitted manuscript. You posted new comments. 14 Jul 2022 Interactive review forum activated automatically. 11 Jul 2022 Review of Reviewer 1 is finalized. 19 Jun 2022 Submitting Author submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be412313672, createdName=军爷123321, createdTime=Sat Aug 20 09:01:55 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089762, encodeId=11b72089e62ab, content=偏重的研究方向：外科 经验分享：各位大佬，快2个月了只有1个审稿人给了意见，请问用什么途径催稿呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85af6425685, createdName=ms8000000359760847, createdTime=Thu Sep 22 13:45:29 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225936, encodeId=86c31225936fe, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：4个审稿人都审稿结束了，进入review finalized 这个状态10天了，有知道这是什么情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=219a6417862, createdName=ms1000000108142926, createdTime=Sun Jun 12 10:16:37 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230074, encodeId=37db12300e4eb, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：真垃圾，三个审稿人都同意发表了，主编最后给拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bc0e6387745, createdName=ms6000001401670212, createdTime=Sat Jul 02 08:09:47 CST 2022, time=2022-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243293, encodeId=768a124329312, content=请问现在frontiers系列被预警概率大不大啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ffe2800746, createdName=504528319, createdTime=Mon Sep 05 13:11:52 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226035, encodeId=f9721226035b8, content=？？？？？？？？？？？？？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53128143603, createdName=ms8000001039313949, createdTime=Sun Jun 12 21:02:14 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238991, encodeId=14b4123899110, content=请问下这个是sci吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56145605225, createdName=ms2000001619512986, createdTime=Tue Aug 16 11:17:01 CST 2022, time=2022-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239374, encodeId=44d212393e493, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：22年2月份投过一次，1个月2个审稿意见返回，返修后1周接受。现在Frontiers稿件超级多，找不到编辑和审稿人都很常见，审稿时间随之延长。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97a06490553, createdName=TMAC1992, createdTime=Wed Aug 17 20:55:55 CST 2022, time=2022-08-17, status=1, ipAttribution=)]

2022-07-02 ms6000001401670212

审稿速度:1.0 | 投稿命中率:50.0
经验分享：真垃圾，三个审稿人都同意发表了，主编最后给拒了

70 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=1240475, encodeId=677e12404e5c0, content=Independent Review 等第2个审稿人意见已经2个多月了。。凉凉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2665416535, createdName=一路同行, createdTime=Tue Aug 23 10:39:29 CST 2022, time=2022-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095213, encodeId=ad3b209521358, content=这个杂志版面费3500美元？那么贵啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99308103880, createdName=ms9000001756415644, createdTime=Fri Oct 21 16:33:42 CST 2022, time=2022-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239942, encodeId=84121239942ce, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：骨科 经验分享：小修一次，接收挺快 15 Aug 2022 Article accepted for publication. 20 Jul 2022 Review of Review Editor 2 finalized. Submitting Author re-submitted manuscript. You posted new comments. 14 Jul 2022 Interactive review forum activated automatically. 11 Jul 2022 Review of Reviewer 1 is finalized. 19 Jun 2022 Submitting Author submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be412313672, createdName=军爷123321, createdTime=Sat Aug 20 09:01:55 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089762, encodeId=11b72089e62ab, content=偏重的研究方向：外科 经验分享：各位大佬，快2个月了只有1个审稿人给了意见，请问用什么途径催稿呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85af6425685, createdName=ms8000000359760847, createdTime=Thu Sep 22 13:45:29 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225936, encodeId=86c31225936fe, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：4个审稿人都审稿结束了，进入review finalized 这个状态10天了，有知道这是什么情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=219a6417862, createdName=ms1000000108142926, createdTime=Sun Jun 12 10:16:37 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230074, encodeId=37db12300e4eb, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：真垃圾，三个审稿人都同意发表了，主编最后给拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bc0e6387745, createdName=ms6000001401670212, createdTime=Sat Jul 02 08:09:47 CST 2022, time=2022-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243293, encodeId=768a124329312, content=请问现在frontiers系列被预警概率大不大啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ffe2800746, createdName=504528319, createdTime=Mon Sep 05 13:11:52 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226035, encodeId=f9721226035b8, content=？？？？？？？？？？？？？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53128143603, createdName=ms8000001039313949, createdTime=Sun Jun 12 21:02:14 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238991, encodeId=14b4123899110, content=请问下这个是sci吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56145605225, createdName=ms2000001619512986, createdTime=Tue Aug 16 11:17:01 CST 2022, time=2022-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239374, encodeId=44d212393e493, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：22年2月份投过一次，1个月2个审稿意见返回，返修后1周接受。现在Frontiers稿件超级多，找不到编辑和审稿人都很常见，审稿时间随之延长。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97a06490553, createdName=TMAC1992, createdTime=Wed Aug 17 20:55:55 CST 2022, time=2022-08-17, status=1, ipAttribution=)]

2022-09-05 504528319

请问现在frontiers系列被预警概率大不大啊？

41 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1240475, encodeId=677e12404e5c0, content=Independent Review 等第2个审稿人意见已经2个多月了。。凉凉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2665416535, createdName=一路同行, createdTime=Tue Aug 23 10:39:29 CST 2022, time=2022-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095213, encodeId=ad3b209521358, content=这个杂志版面费3500美元？那么贵啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99308103880, createdName=ms9000001756415644, createdTime=Fri Oct 21 16:33:42 CST 2022, time=2022-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239942, encodeId=84121239942ce, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：骨科 经验分享：小修一次，接收挺快 15 Aug 2022 Article accepted for publication. 20 Jul 2022 Review of Review Editor 2 finalized. Submitting Author re-submitted manuscript. You posted new comments. 14 Jul 2022 Interactive review forum activated automatically. 11 Jul 2022 Review of Reviewer 1 is finalized. 19 Jun 2022 Submitting Author submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be412313672, createdName=军爷123321, createdTime=Sat Aug 20 09:01:55 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089762, encodeId=11b72089e62ab, content=偏重的研究方向：外科 经验分享：各位大佬，快2个月了只有1个审稿人给了意见，请问用什么途径催稿呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85af6425685, createdName=ms8000000359760847, createdTime=Thu Sep 22 13:45:29 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225936, encodeId=86c31225936fe, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：4个审稿人都审稿结束了，进入review finalized 这个状态10天了，有知道这是什么情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=219a6417862, createdName=ms1000000108142926, createdTime=Sun Jun 12 10:16:37 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230074, encodeId=37db12300e4eb, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：真垃圾，三个审稿人都同意发表了，主编最后给拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bc0e6387745, createdName=ms6000001401670212, createdTime=Sat Jul 02 08:09:47 CST 2022, time=2022-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243293, encodeId=768a124329312, content=请问现在frontiers系列被预警概率大不大啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ffe2800746, createdName=504528319, createdTime=Mon Sep 05 13:11:52 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226035, encodeId=f9721226035b8, content=？？？？？？？？？？？？？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53128143603, createdName=ms8000001039313949, createdTime=Sun Jun 12 21:02:14 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238991, encodeId=14b4123899110, content=请问下这个是sci吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56145605225, createdName=ms2000001619512986, createdTime=Tue Aug 16 11:17:01 CST 2022, time=2022-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239374, encodeId=44d212393e493, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：22年2月份投过一次，1个月2个审稿意见返回，返修后1周接受。现在Frontiers稿件超级多，找不到编辑和审稿人都很常见，审稿时间随之延长。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97a06490553, createdName=TMAC1992, createdTime=Wed Aug 17 20:55:55 CST 2022, time=2022-08-17, status=1, ipAttribution=)]

2022-06-12 ms8000001039313949

？？？？？？？？？？？？？？？

46 0

[GetPortalCommentsPageByObjectIdResponse(id=1240475, encodeId=677e12404e5c0, content=Independent Review 等第2个审稿人意见已经2个多月了。。凉凉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2665416535, createdName=一路同行, createdTime=Tue Aug 23 10:39:29 CST 2022, time=2022-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095213, encodeId=ad3b209521358, content=这个杂志版面费3500美元？那么贵啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99308103880, createdName=ms9000001756415644, createdTime=Fri Oct 21 16:33:42 CST 2022, time=2022-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239942, encodeId=84121239942ce, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：骨科 经验分享：小修一次，接收挺快 15 Aug 2022 Article accepted for publication. 20 Jul 2022 Review of Review Editor 2 finalized. Submitting Author re-submitted manuscript. You posted new comments. 14 Jul 2022 Interactive review forum activated automatically. 11 Jul 2022 Review of Reviewer 1 is finalized. 19 Jun 2022 Submitting Author submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be412313672, createdName=军爷123321, createdTime=Sat Aug 20 09:01:55 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089762, encodeId=11b72089e62ab, content=偏重的研究方向：外科 经验分享：各位大佬，快2个月了只有1个审稿人给了意见，请问用什么途径催稿呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85af6425685, createdName=ms8000000359760847, createdTime=Thu Sep 22 13:45:29 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225936, encodeId=86c31225936fe, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：4个审稿人都审稿结束了，进入review finalized 这个状态10天了，有知道这是什么情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=219a6417862, createdName=ms1000000108142926, createdTime=Sun Jun 12 10:16:37 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230074, encodeId=37db12300e4eb, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：真垃圾，三个审稿人都同意发表了，主编最后给拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bc0e6387745, createdName=ms6000001401670212, createdTime=Sat Jul 02 08:09:47 CST 2022, time=2022-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243293, encodeId=768a124329312, content=请问现在frontiers系列被预警概率大不大啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ffe2800746, createdName=504528319, createdTime=Mon Sep 05 13:11:52 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226035, encodeId=f9721226035b8, content=？？？？？？？？？？？？？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53128143603, createdName=ms8000001039313949, createdTime=Sun Jun 12 21:02:14 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238991, encodeId=14b4123899110, content=请问下这个是sci吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56145605225, createdName=ms2000001619512986, createdTime=Tue Aug 16 11:17:01 CST 2022, time=2022-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239374, encodeId=44d212393e493, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：22年2月份投过一次，1个月2个审稿意见返回，返修后1周接受。现在Frontiers稿件超级多，找不到编辑和审稿人都很常见，审稿时间随之延长。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97a06490553, createdName=TMAC1992, createdTime=Wed Aug 17 20:55:55 CST 2022, time=2022-08-17, status=1, ipAttribution=)]

2022-08-16 ms2000001619512986

请问下这个是sci吗？

48 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1240475, encodeId=677e12404e5c0, content=Independent Review 等第2个审稿人意见已经2个多月了。。凉凉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2665416535, createdName=一路同行, createdTime=Tue Aug 23 10:39:29 CST 2022, time=2022-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095213, encodeId=ad3b209521358, content=这个杂志版面费3500美元？那么贵啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99308103880, createdName=ms9000001756415644, createdTime=Fri Oct 21 16:33:42 CST 2022, time=2022-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239942, encodeId=84121239942ce, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：骨科 经验分享：小修一次，接收挺快 15 Aug 2022 Article accepted for publication. 20 Jul 2022 Review of Review Editor 2 finalized. Submitting Author re-submitted manuscript. You posted new comments. 14 Jul 2022 Interactive review forum activated automatically. 11 Jul 2022 Review of Reviewer 1 is finalized. 19 Jun 2022 Submitting Author submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be412313672, createdName=军爷123321, createdTime=Sat Aug 20 09:01:55 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089762, encodeId=11b72089e62ab, content=偏重的研究方向：外科 经验分享：各位大佬，快2个月了只有1个审稿人给了意见，请问用什么途径催稿呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85af6425685, createdName=ms8000000359760847, createdTime=Thu Sep 22 13:45:29 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225936, encodeId=86c31225936fe, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：4个审稿人都审稿结束了，进入review finalized 这个状态10天了，有知道这是什么情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=219a6417862, createdName=ms1000000108142926, createdTime=Sun Jun 12 10:16:37 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230074, encodeId=37db12300e4eb, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：真垃圾，三个审稿人都同意发表了，主编最后给拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bc0e6387745, createdName=ms6000001401670212, createdTime=Sat Jul 02 08:09:47 CST 2022, time=2022-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243293, encodeId=768a124329312, content=请问现在frontiers系列被预警概率大不大啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ffe2800746, createdName=504528319, createdTime=Mon Sep 05 13:11:52 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226035, encodeId=f9721226035b8, content=？？？？？？？？？？？？？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53128143603, createdName=ms8000001039313949, createdTime=Sun Jun 12 21:02:14 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238991, encodeId=14b4123899110, content=请问下这个是sci吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56145605225, createdName=ms2000001619512986, createdTime=Tue Aug 16 11:17:01 CST 2022, time=2022-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239374, encodeId=44d212393e493, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：22年2月份投过一次，1个月2个审稿意见返回，返修后1周接受。现在Frontiers稿件超级多，找不到编辑和审稿人都很常见，审稿时间随之延长。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97a06490553, createdName=TMAC1992, createdTime=Wed Aug 17 20:55:55 CST 2022, time=2022-08-17, status=1, ipAttribution=)]

2022-08-17 TMAC1992

审稿速度:1.0
偏重的研究方向：肿瘤
经验分享：22年2月份投过一次，1个月2个审稿意见返回，返修后1周接受。现在Frontiers稿件超级多，找不到编辑和审稿人都很常见，审稿时间随之延长。

42 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务